Tisento Therapeutics
We listen, learn, and deliver.
Cambridge, United States · Founded 2023 · $81.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- tisentotx.com
- Total Funding
- $81.0M
- Last Round
- $81.0M Series AAug 2023
- Rounds
- 1
About
At Tisento, we believe meaningful innovation starts with listening. We listen to those living with serious diseases to understand the impact of disease on their lives. We are a committed team of industry veterans working closely with a broad network of collaborators. Our current focus is on developing zagociguat as a treatment for individuals with MELAS, a debilitating disease with no effective treatments.
Summary
Tisento Therapeutics is a Biotech company based in Cambridge, United States, founded in 2023. It has raised $81.0M in total across 1 round, most recently a $81.0M Series A round in Aug 2023. Investors include Polaris Partners, Sanofi Ventures and J. Wood Capital Advisors.
Funding History
Aug 2023
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tisento-therapeutics"><img src="https://indexed.vc/api/badge/company/tisento-therapeutics" alt="Tisento Therapeutics on Indexed.vc" width="260" height="76" /></a>